Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial

BACKGROUND: Over half of the patients were diagnosed with colorectal cancer after 70 years of age. The choice of the most suitable chemotherapy strategy is the major challenge for elderly patients. Previous trials indicated that elderly patients with stage II/III colorectal cancer obtained no signif...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yazhou, Liu, Ping, Zhang, Yuanchuan, Deng, Xiangbing, Meng, Wenjian, Wei, Mingtian, Yang, Tinghan, Wang, Ziqiang, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465020/
https://www.ncbi.nlm.nih.gov/pubmed/26021722
http://dx.doi.org/10.1186/s13063-015-0753-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465020/
https://www.ncbi.nlm.nih.gov/pubmed/26021722
http://dx.doi.org/10.1186/s13063-015-0753-7

Ejemplares similares